Delete
Are you sure you want to delete the Feed “https://www.fiercepharma.com/rss/xml”? All of the following related items will be deleted:
Summary
- Feeds: 1
- Entries: 39
Objects
- Feed: https://www.fiercepharma.com/rss/xml
- Entry: <a href="https://www.fiercepharma.com/pharma/eha-jj-sharpens-myeloma-edge-talvey-darzalex-faspro-combo-proves-its-worth-earlier-disease" hreflang="en">EHA: J&J sharpens myeloma edge as Talvey, Darzalex Faspro combo proves its worth in earlier disease stage </a>
- Entry: <a href="https://www.fiercepharma.com/regulatory/cms-proposes-permanent-framework-medicare-drug-price-negotiations" hreflang="en">CMS proposes permanent framework for Medicare drug price negotiations</a>
- Entry: <a href="https://www.fiercepharma.com/pharma/oral-glp-1-tracker-launch-trajectories-lilly-foundayo-novo-wegovy-pill" hreflang="en">The Oral GLP-1 Tracker: Novo’s Wegovy keeps gaining ground in obesity market</a>
- Entry: <a href="https://www.fiercepharma.com/pharma/fda-hearing-amgens-tavneos-will-include-findings-independent-review" hreflang="en">FDA hearing on Amgen's Tavneos will include findings from an independent review</a>
- Entry: <a href="https://www.fiercepharma.com/pharma/latest-twist-zepzelca-saga-jazz-and-pharmamar-lung-cancer-drug-fails-phase-3-test" hreflang="en">In latest twist in Zepzelca saga, Jazz and PharmaMar lung cancer drug fails phase 3 test</a>
- Entry: <a href="https://www.fiercepharma.com/pharma/fierce-pharma-regulatory-tracker-2026" hreflang="en">Regulatory tracker: Novo's oral GLP-1 picks up UK approval</a>
- Entry: <a href="https://www.fiercepharma.com/marketing/eli-lilly-biogen-eisai-and-genentech-sponsor-new-lets-talk-alzheimers-podcast" hreflang="en">Lilly, Biogen, Eisai and Genentech sponsor new ‘Let’s Talk Alzheimer’s’ podcast</a>
- Entry: <a href="https://www.fiercepharma.com/pharma/astellas-ceo-5-year-plan-takeda-psoriasis-win-ra-china-bridge-program" hreflang="en">Fierce Pharma Asia—Astellas CEO’s 5-year plan; Takeda’s psoriasis win; RA’s China bridge program</a>
- Entry: <a href="https://www.fiercepharma.com/pharma/not-simply-saving-cost-inside-astellas-ceo-5-year-strategy-counter-xtandi-patent-cliff" hreflang="en">‘Not simply saving cost’: Inside Astellas CEO’s 5-year strategy to counter Xtandi’s patent cliff</a>
- Entry: <a href="https://www.fiercepharma.com/biotech/genentech-executes-another-round-layoffs-3-vps-axed" hreflang="en">Genentech executes another round of layoffs, with 3 VPs axed</a>
- Entry: <a href="https://www.fiercepharma.com/ai-and-machine-learning/all-hhs-agencies-saw-ai-use-case-increases-fy-2025-bipartisan-policy-center" hreflang="en">AI use is surging across HHS, jumping 148% at the FDA in 2025, Bipartisan Policy Center data finds</a>
- Entry: <a href="https://www.fiercepharma.com/pharma/novo-reports-cybersecurity-breach-tells-clinical-trial-patients-remain-vigilant" hreflang="en">Novo reports data breach, tells clinical trial patients to 'remain vigilant'</a>
- Entry: <a href="https://www.fiercepharma.com/pharma/joint-initiative-5-eu-countries-calls-unified-approach-pharma-framework-amid-us-drug-pricing" hreflang="en">Joint initiative of 5 EU countries calls for 'unified approach' to pharma framework amid US drug pricing pressure</a>
- Entry: <a href="https://www.fiercepharma.com/pharma/jj-shows-results-trial-could-lead-rare-disease-expansion-imaavy" hreflang="en">J&J eyes rare disease expansion for blockbuster-to-be Imaavy with trial win</a>
- Entry: <a href="https://www.fiercepharma.com/marketing/madrigal-takes-giant-inflatable-liver-us-tour-disease-awareness-push" hreflang="en">Madrigal takes giant inflatable liver on US tour in disease awareness push</a>
- Entry: <a href="https://www.fiercepharma.com/marketing/olixir-ny-teams-crohns-colitis-foundation-its-spill-your-guts-campaign" hreflang="en">Olixir NY teams with Crohn's & Colitis Foundation for ‘Spill Your Guts’ campaign </a>
- Entry: <a href="https://www.fiercepharma.com/pharma/if-thats-not-acceleration-i-dont-know-what-novo-nordisk-ceo-doustdar-talks-leadership-new" hreflang="en">‘I’m a lot more optimistic today’: Mike Doustdar tells Fierce about pivotal first year as Novo Nordisk CEO </a>
- Entry: <a href="https://www.fiercepharma.com/biotech/takedas-tyk2-inhibitor-beats-bristol-myers-sotyktu-psoriasis-showdown" hreflang="en">Takeda’s TYK2 inhibitor beats Bristol Myers’ Sotyktu in phase 3 psoriasis showdown</a>
- Entry: <a href="https://www.fiercepharma.com/marketing/eli-lilly-yells-action-authentic-patient-portrayals-tribeca-festival" hreflang="en">Eli Lilly yells ‘action’ on authentic patient portrayals at Tribeca Festival</a>
- Entry: <a href="https://www.fiercepharma.com/pharma/amid-growing-industry-backlash-germanys-healthcare-reform-plan-pfizer-ceo-bourla-re" hreflang="en">Pfizer CEO Bourla reconsiders German investments as industry takes aim at healthcare reform plan: Reuters </a>
- Entry: <a href="https://www.fiercepharma.com/sponsored/how-lab-data-powers-precision-commercialization-drive-therapy-adoption" hreflang="en">How lab data powers precision commercialization to drive therapy adoption</a>
- Entry: <a href="https://www.fiercepharma.com/sponsored/legacy-approach-real-world-data-costing-you" hreflang="en">The legacy approach to real-world data is costing you</a>
- Entry: <a href="https://www.fiercepharma.com/sponsored/why-mrd-becoming-central-oncology-drug-development" hreflang="en">Why MRD is becoming central to oncology drug development</a>
- Entry: <a href="https://www.fiercepharma.com/sponsored/asco-2026-showed-precision-oncologys-next-challenge-translation" hreflang="en">ASCO 2026 showed that precision oncology’s next challenge is translation</a>
- Entry: <a href="https://www.fiercepharma.com/sponsored/european-commission-approves-cinnagens-zandoriahr-teriparatide-biosimilar-osteoporosis" hreflang="en">European Commission Approves CinnaGen’s Zandoriah® (teriparatide biosimilar) for Osteoporosis in Adults</a>
- Entry: <a href="https://www.fiercepharma.com/pharma/lilly-oncology-chief-went-extremely-nervous-blown-away-new-jaypirca-cll-data" hreflang="en">Lilly oncology chief went from ‘extremely nervous’ to ‘blown away’ by new Jaypirca CLL data</a>
- Entry: <a href="https://www.fiercepharma.com/manufacturing/eisai-snares-government-manufacturing-grant-it-brings-leqembi-packaging-uk-65m" hreflang="en">Eisai snares government manufacturing grant as it brings Leqembi packaging to UK with $65M expansion</a>
- Entry: <a href="https://www.fiercepharma.com/pharma/mercks-welireg-keytruda-pairing-sticks-landing-adjuvant-kidney-cancer-treatment-new-fda-nod" hreflang="en">Merck's Welireg-Keytruda pairing sticks the landing in adjuvant kidney cancer treatment with new FDA nod</a>
- Entry: <a href="https://www.fiercepharma.com/marketing/iqvia-taps-ai-put-overlooked-prescribers-marketers-maps" hreflang="en">IQVIA taps AI to put overlooked prescribers on marketers’ maps</a>
- Entry: <a href="https://www.fiercepharma.com/pharma/once-fda-pathway-speed-its-approval-sanfoi-gains-late-expansion-tzield" hreflang="en">Sanofi, once on FDA course for speedy approval, gains late expansion for Tzield</a>
- Entry: <a href="https://www.fiercepharma.com/sponsored/beyond-china-and-japan-how-biopharma-expanding-rare-disease-access-across-asia-pacific" hreflang="en">Beyond China and Japan: How biopharma is expanding rare disease access across Asia-Pacific</a>
- Entry: <a href="https://www.fiercepharma.com/pharma/germany-backs-plan-install-variable-discount-pricing-drugs" hreflang="en">Germany backs off plan to install variable discount pricing on drugs: report</a>
- Entry: <a href="https://www.fiercepharma.com/manufacturing/recipharm-pump-multi-millions-us-manufacturing-operations" hreflang="en">Recipharm channels ‘multi-million-dollar' US manufacturing upgrade, targeting domestic biologics demand</a>
- Entry: <a href="https://www.fiercepharma.com/marketing/stealth-biotherapeutics-removes-cloak-become-mighty" hreflang="en">Stealth BioTherapeutics removes cloak to become Mighty </a>
- Entry: <a href="https://www.fiercepharma.com/marketing/phrma-talks-power-medicines-first-new-campaign" hreflang="en">PhRMA talks up the power of ‘Medicines First’ in new campaign </a>
- Entry: <a href="https://www.fiercepharma.com/pharma/moderna-hires-banque-lead-commercial-creates-larger-role-hoge" hreflang="en">Moderna hires Novartis vet to lead commercial, upsizes role for Hoge as potential launches loom</a>
- Entry: <a href="https://www.fiercepharma.com/pharma/fda-uk-drug-regulator-deepen-transatlantic-ties-new-liaison-program" hreflang="en">FDA, UK drug regulator deepen transatlantic ties with new liaison program</a>
- Entry: <a href="https://www.fiercepharma.com/marketing/deepintent-gives-helix-ai-twist-help-marketers-query-data" hreflang="en">DeepIntent gives Helix an AI twist to help marketers query data</a>
- Entry: <a href="https://www.fiercepharma.com/pharma/ma-volume-and-value-indicate-biopharma-ecosystem-back-full-health-pwc" hreflang="en">'Biopharma ecosystem is back to full health,' fueled by M&A: PwC</a>